| 000 | 01778 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513213612.0 | ||
| 264 | 0 | _c20000828 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0100-879X | ||
| 024 | 7 |
_a10.1590/s0100-879x2000000700009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Souza, C A | |
| 245 | 0 | 0 |
_aAmifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study. _h[electronic resource] |
| 260 |
_bBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas _cJul 2000 |
||
| 300 |
_a791-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmifostine _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aCytoprotection _xdrug effects |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRadiation-Protective Agents _xadverse effects |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSantini, G | |
| 700 | 1 | _aMarino, G | |
| 700 | 1 | _aNati, S | |
| 700 | 1 | _aCongiu, A M | |
| 700 | 1 | _aVigorito, A C | |
| 700 | 1 | _aDamasio, E | |
| 773 | 0 |
_tBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas _gvol. 33 _gno. 7 _gp. 791-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1590/s0100-879x2000000700009 _zAvailable from publisher's website |
| 999 |
_c10831622 _d10831622 |
||